Retrospective single-center review of 80 HFrEF patients added SGLT2 inhibitors on stable guideline-directed therapy, with ...
More than half of patients with myelofibrosis and low platelets treated with Vonjo saw platelets rise 58% and hemoglobin levels improve. More than half of patients with low platelets (thrombocytopenia ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results